SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-10-020059
Filing Date
2010-04-16
Accepted
2010-04-16 14:39:24
Documents
7
Period of Report
2010-04-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-8184_48k.htm 8-K 41191
2 EX-1.1 a10-8184_4ex1d1.htm EX-1.1 228177
3 EX-5.1 a10-8184_4ex5d1.htm EX-5.1 14030
4 EX-99.1 a10-8184_4ex99d1.htm EX-99.1 10622
5 EX-99.2 a10-8184_4ex99d2.htm EX-99.2 10883
6 GRAPHIC g81844mmi001.jpg GRAPHIC 4411
7 GRAPHIC g81844mli001.jpg GRAPHIC 4411
  Complete submission text file 0001104659-10-020059.txt   318915
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23272 | Film No.: 10754465
SIC: 2836 Biological Products, (No Diagnostic Substances)